| Detected | Trial | Change |
|---|---|---|
| 2026-06-06 | NCT07217587 Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized… |
date change Completion pushed: 2028-12-11 -> 2029-07-31 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT07217587 | Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized… | Myasthenia Gravis | Recruiting |
| Phase 2 | |||
| NCT07025330 | A Study of Efgartigimod in Patients With IgG4-Related Disease | IgG4-related Disease | Recruiting |
| NCT06831058 | A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura… | Immune-mediated Thrombotic Thrombocytopenic Purpura | Recruiting |
| Phase 1/2 | |||
| NCT07011589 | Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART) | Epidermolysis Bullosa (EB) | Not Yet Recruiting |
| Not specified | |||
| NCT06298565 | A Non-interventional, Post-authorisation Safety Study of Patients Treated With… | Myasthenia Gravis | Recruiting |
| NCT06299748 | A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes… | Myasthenia Gravis | Recruiting |